Results 291 to 300 of about 47,434 (363)

White paper on best practices for translational research in neuroendocrine neoplasms

Journal of Neuroendocrinology, Volume 37, Issue 10, October 2025.
Abstract Basic and translational investigations play a crucial role in advancing our understanding of neuroendocrine neoplasms (NENs). In this white paper by the Basic and Translational Research Group of the European Neuroendocrine Tumor Society, we discuss the qualities and drawbacks of current disease models and propose good practices for integrating
Jerome Cros, Oriol Casanovas, Justo P. Castaño, Talya Dayton, Alejandro Garcia Alvarez, Benjamin Gibert, Michele Simbolo, Timon Vandamme, Mauro Cives, Ilaria Marinoni, on behalf of the ENETS Basic and Translational Research Group (BTRG)   +10 more
wiley   +1 more source

Personalized circulating tumor DNA dynamics inform survival and response to immune checkpoint blockade in recurrent/metastatic head and neck cancer. [PDF]

NPJ Precis Oncol
Ruiz-Torres DA, Merkin RD, Bryan ME, Mendel J, Efthymiou V, Roberts T, Patel MJ, Park JC, Chevalier A, Murray C, Gates L, Pipinikas C, Stott SL, Fisch AS, Wirth LJ, Faden DL.   +15 more
europepmc   +1 more source

Personalized care for patients with EGFR‐mutant nonsmall cell lung cancer: Navigating early to advanced disease management

CA: A Cancer Journal for Clinicians, Volume 75, Issue 5, Page 387-409, September/October 2025.
Abstract The discovery of activating mutations in the epidermal growth factor receptor (EGFR) gene has revolutionized the management of lung cancer, enabling the development of targeted tyrosine kinase inhibitors (TKIs). These therapies offer improved survival and reduced side effects compared with conventional treatments.
Maxime Borgeaud, Timothée Olivier, Jair Bar, Stephanie Pei Li Saw, Kaushal Parikh, Giuseppe Luigi Banna, Claudio De Vito, Jill Feldman, Xiuning Le, Alfredo Addeo   +9 more
wiley   +1 more source

Utility and Future Perspectives of Circulating Tumor DNA Analysis in Non-Small Cell Lung Cancer Patients in the Era of Perioperative Chemo-Immunotherapy. [PDF]

Cells
Ohara S, Suda K, Tsutani Y.
europepmc   +1 more source

Quantitative monitoring and mutations of ctDNA before and after non-small cell lung cancer radical surgery*

, 2019
Xiangqi Chen, Tingyan Lin, Zhisen Gao, Jiangjiang Xu, Rui Feng, Sheng Yang, Shuchen Chen, Mingqiang Kang   +7 more
openalex   +2 more sources

Circulating tumor DNA to anticipate loco-regional recurrence in early-stage breast cancer: a proof-of-concept study. [PDF]

Front Oncol
Appierto V, Tamborini E, Tiberio P, Busico A, De Cecco L, Silvestri M, De Marco C, Cavadini E, De Santis MC, Folli S, Scaperrotta G, Manitto R, Vingiani A, Pruneri G, Di Cosimo S.   +14 more
europepmc   +1 more source

Evaluating sensitivity of NGS-based mutation detection across diverse sample types in prostate cancer. [PDF]

Diagn Pathol
Jiang K, Dai Z, Chen J, Gao Z, Tong H, Liu H, Huang G, Liu F, Ma Y, Pan E, Yin J, Yao L, Wang L.   +12 more
europepmc   +1 more source

Abstract 3769: Detection of allele specific loss of heterozygosity in 70,000 patients with ctDNA

, 2019
Jing Hua Zhao, Stephen R. Fairclough, Darya Chudova, Richard B. Lanman, AmirAli Talasaz, Aaron Hardin   +5 more
openalex   +1 more source

Tumor-informed circulating tumor DNA detection for personalized monitoring of treatment response in epithelial ovarian cancer. [PDF]

Pract Lab Med
Kang SW, Kang OJ, Lee YJ, Jung HJ, Lee MS, Lee JY, Kim YM, Lee SW.   +7 more
europepmc   +1 more source

Tumor-informed circulating tumor DNA assay for surveillance post-liver transplantation in patients with hepatocellular and cholangiocarcinoma. [PDF]

J Gastrointest Oncol
Abdelrahim M, Connor AA, Esmail A, Elaileh A, Farhat S, Kodali S, Victor DW, Brombosz EW, Saharia A, Moore LW, Ghobrial RM.   +10 more
europepmc   +1 more source